1. Home
  2. MAX vs EOLS Comparison

MAX vs EOLS Comparison

Compare MAX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

HOLD

Current Price

$13.07

Market Cap

551.1M

Sector

Industrials

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.85

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAX
EOLS
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
551.1M
444.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MAX
EOLS
Price
$13.07
$6.85
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$17.00
$20.80
AVG Volume (30 Days)
503.1K
1.4M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,123,093,000.00
$285,823,000.00
Revenue This Year
$30.80
$14.36
Revenue Next Year
$9.28
$23.27
P/E Ratio
N/A
N/A
Revenue Growth
64.86
15.10
52 Week Low
$7.33
$5.71
52 Week High
$13.92
$17.12

Technical Indicators

Market Signals
Indicator
MAX
EOLS
Relative Strength Index (RSI) 58.29 50.64
Support Level $12.37 $6.36
Resistance Level $13.92 $7.15
Average True Range (ATR) 0.54 0.29
MACD 0.09 -0.03
Stochastic Oscillator 67.07 55.74

Price Performance

Historical Comparison
MAX
EOLS

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: